Browsing by Titles

Showing results 1 to 4 of 4

  • Lee, Eun Hye ; 
  • Chung, Jae-Wook ; 
  • Sung, Eunji ; 
  • Yoon, Bo Hyun ; 
  • Jeon, Minji ; 
  • Park, Song ; 
  • Chun, So Young ; 
  • Lee, Jun Nyung ; 
  • Kim, Bum Soo ; 
  • Kim, Hyun Tae ; 
  • et al
  • 2022-11
  • Lee, Eun Hye. (2022-11). Anti-Metastatic Effect of Pyruvate Dehydrogenase Kinase 4 Inhibition in Bladder Cancer via the ERK, SRC, and JNK Pathways. International Journal of Molecular Sciences, 23(21). doi: 10.3390/ijms232113240
  • MDPI
  • View : 589
  • Download : 0
  • Lee, Eun Hye ; 
  • Lee, Jun Nyung ; 
  • Park, Song ; 
  • Chun, So Young ; 
  • Yoon, Bo Hyun ; 
  • Chung, Jae-Wook ; 
  • Choi, Seock Hwan ; 
  • Kim, Bum Soo ; 
  • Kim, Hyun Tae ; 
  • Kim, Tae Hwan ; 
  • et al
  • 2022-07
  • Lee, Eun Hye. (2022-07). Inhibition of TRPM7 suppresses migration and invasion of prostate cancer cells via inactivation of ERK1/2, Src and Akt pathway signaling. Journal of Men's Health, 18(7). doi: 10.31083/j.jomh1807144
  • Elsevier BV
  • View : 224
  • Download : 0
  • Park, Song ; 
  • Kwon, Wookbong ; 
  • Park, Jin-Kyu ; 
  • Baek, Su-Min ; 
  • Lee, Seoung-Woo ; 
  • Cho, Gil-Jae ; 
  • Ha, Yun-Sok ; 
  • Lee, Jun Nyung ; 
  • Kwon, Tae Gyun ; 
  • Kim, Myoung Ok ; 
  • et al
  • 2020-07
  • Park, Song. (2020-07). Suppression of cathepsin a inhibits growth, migration, and invasion by inhibiting the p38 MAPK signaling pathway in prostate cancer. doi: 10.1016/j.abb.2020.108407
  • Academic Press
  • View : 681
  • Download : 0

ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state

  • Kwon, Wookbong ; 
  • Choi, Seong-Kyoon ; 
  • Kim, Daehwan ; 
  • Kim, Hyeon-Gyeom ; 
  • Park, Jin-Kyu ; 
  • Han, Jee Eun ; 
  • Cho, Gil-Jae ; 
  • Yun, Sungho ; 
  • Yu, Wookyung ; 
  • Han, Se-Hyeon ; 
  • et al
  • 2021-09
  • Kwon, Wookbong. (2021-09). ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state. Journal of Experimental & Clinical Cancer Research, 40(1). doi: 10.1186/s13046-021-02094-3
  • Springer Science and Business Media LLC
  • View : 631
  • Download : 158
1